Rotavirus vaccines: a long and difficult journey

Diarrhea is the second cause of death worldwide. The main causative agent in infants and children less than 5 years is rotavirus. Consequently, for the World Health Organization and the Global Alliance for Vaccines and Immunization (GAVI), rotavirus vaccination is an urgent priority. The global dist...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gastroenterología y hepatología 2011-12, Vol.34 (10), p.694-700
Hauptverfasser: Campins Martí, Magda, Moraga-Llop, Fernando A
Format: Artikel
Sprache:spa
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 700
container_issue 10
container_start_page 694
container_title Gastroenterología y hepatología
container_volume 34
creator Campins Martí, Magda
Moraga-Llop, Fernando A
description Diarrhea is the second cause of death worldwide. The main causative agent in infants and children less than 5 years is rotavirus. Consequently, for the World Health Organization and the Global Alliance for Vaccines and Immunization (GAVI), rotavirus vaccination is an urgent priority. The global distribution of rotavirus serotypes varies from country to country, but in 80-90% of cases is caused by five types: G1P[8], G2P[4], G3P[8], G4P[8] and G9P[8]. Currently, two rotavirus vaccines are available, an attenuated monovalent G1P[8] vaccine, and a pentavalent human-bovine recombinant vaccine containing five strains of bovine WC3 rotavirus, four with a gene codifying the VP7 protein of human rotaviruses G1, G2, G3 and G4, and a fifth expressing the VP4 P[8] genotype.
doi_str_mv 10.1016/j.gastrohep.2011.09.003
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_909292656</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>909292656</sourcerecordid><originalsourceid>FETCH-LOGICAL-p140t-4867d775e64619c0d4310947b69e5040a1f97292c872db5984cfbae9fd0f28563</originalsourceid><addsrcrecordid>eNo1j8tKw0AYRmeh2Fp9BZ2dq8R_7hl3UrxBQRBdh8lc6oQ0EzNJoW-vaF2dzTkffAhdEygJEHnblluTpzF9-qGkQEgJugRgJ2gJlEAhFIgFOs-5BaCCUX2GFpQSQiXjSwRvaTL7OM4Z7421sff5DhvcpX6LTe-wiyFEO3cTbtM89v5wgU6D6bK_PHKFPh4f3tfPxeb16WV9vykGwmEqeCWVU0p4ySXRFhxnBDRXjdReAAdDglZUU1sp6hqhK25DY7wODgKthGQrdPO3O4zpa_Z5qncxW991pvdpzrUG_ZPLX_PqaM7Nzrt6GOPOjIf6_yT7BqA7Uyg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>909292656</pqid></control><display><type>article</type><title>Rotavirus vaccines: a long and difficult journey</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Campins Martí, Magda ; Moraga-Llop, Fernando A</creator><creatorcontrib>Campins Martí, Magda ; Moraga-Llop, Fernando A</creatorcontrib><description>Diarrhea is the second cause of death worldwide. The main causative agent in infants and children less than 5 years is rotavirus. Consequently, for the World Health Organization and the Global Alliance for Vaccines and Immunization (GAVI), rotavirus vaccination is an urgent priority. The global distribution of rotavirus serotypes varies from country to country, but in 80-90% of cases is caused by five types: G1P[8], G2P[4], G3P[8], G4P[8] and G9P[8]. Currently, two rotavirus vaccines are available, an attenuated monovalent G1P[8] vaccine, and a pentavalent human-bovine recombinant vaccine containing five strains of bovine WC3 rotavirus, four with a gene codifying the VP7 protein of human rotaviruses G1, G2, G3 and G4, and a fifth expressing the VP4 P[8] genotype.</description><identifier>ISSN: 0210-5705</identifier><identifier>DOI: 10.1016/j.gastrohep.2011.09.003</identifier><identifier>PMID: 22112634</identifier><language>spa</language><publisher>Spain</publisher><subject>Diarrhea - prevention &amp; control ; Diarrhea - virology ; Humans ; Rotavirus Infections - prevention &amp; control ; Rotavirus Vaccines - adverse effects ; Rotavirus Vaccines - immunology</subject><ispartof>Gastroenterología y hepatología, 2011-12, Vol.34 (10), p.694-700</ispartof><rights>Copyright © 2011 Elsevier España, S.L. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22112634$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Campins Martí, Magda</creatorcontrib><creatorcontrib>Moraga-Llop, Fernando A</creatorcontrib><title>Rotavirus vaccines: a long and difficult journey</title><title>Gastroenterología y hepatología</title><addtitle>Gastroenterol Hepatol</addtitle><description>Diarrhea is the second cause of death worldwide. The main causative agent in infants and children less than 5 years is rotavirus. Consequently, for the World Health Organization and the Global Alliance for Vaccines and Immunization (GAVI), rotavirus vaccination is an urgent priority. The global distribution of rotavirus serotypes varies from country to country, but in 80-90% of cases is caused by five types: G1P[8], G2P[4], G3P[8], G4P[8] and G9P[8]. Currently, two rotavirus vaccines are available, an attenuated monovalent G1P[8] vaccine, and a pentavalent human-bovine recombinant vaccine containing five strains of bovine WC3 rotavirus, four with a gene codifying the VP7 protein of human rotaviruses G1, G2, G3 and G4, and a fifth expressing the VP4 P[8] genotype.</description><subject>Diarrhea - prevention &amp; control</subject><subject>Diarrhea - virology</subject><subject>Humans</subject><subject>Rotavirus Infections - prevention &amp; control</subject><subject>Rotavirus Vaccines - adverse effects</subject><subject>Rotavirus Vaccines - immunology</subject><issn>0210-5705</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j8tKw0AYRmeh2Fp9BZ2dq8R_7hl3UrxBQRBdh8lc6oQ0EzNJoW-vaF2dzTkffAhdEygJEHnblluTpzF9-qGkQEgJugRgJ2gJlEAhFIgFOs-5BaCCUX2GFpQSQiXjSwRvaTL7OM4Z7421sff5DhvcpX6LTe-wiyFEO3cTbtM89v5wgU6D6bK_PHKFPh4f3tfPxeb16WV9vykGwmEqeCWVU0p4ySXRFhxnBDRXjdReAAdDglZUU1sp6hqhK25DY7wODgKthGQrdPO3O4zpa_Z5qncxW991pvdpzrUG_ZPLX_PqaM7Nzrt6GOPOjIf6_yT7BqA7Uyg</recordid><startdate>201112</startdate><enddate>201112</enddate><creator>Campins Martí, Magda</creator><creator>Moraga-Llop, Fernando A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201112</creationdate><title>Rotavirus vaccines: a long and difficult journey</title><author>Campins Martí, Magda ; Moraga-Llop, Fernando A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p140t-4867d775e64619c0d4310947b69e5040a1f97292c872db5984cfbae9fd0f28563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2011</creationdate><topic>Diarrhea - prevention &amp; control</topic><topic>Diarrhea - virology</topic><topic>Humans</topic><topic>Rotavirus Infections - prevention &amp; control</topic><topic>Rotavirus Vaccines - adverse effects</topic><topic>Rotavirus Vaccines - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Campins Martí, Magda</creatorcontrib><creatorcontrib>Moraga-Llop, Fernando A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Gastroenterología y hepatología</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Campins Martí, Magda</au><au>Moraga-Llop, Fernando A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rotavirus vaccines: a long and difficult journey</atitle><jtitle>Gastroenterología y hepatología</jtitle><addtitle>Gastroenterol Hepatol</addtitle><date>2011-12</date><risdate>2011</risdate><volume>34</volume><issue>10</issue><spage>694</spage><epage>700</epage><pages>694-700</pages><issn>0210-5705</issn><abstract>Diarrhea is the second cause of death worldwide. The main causative agent in infants and children less than 5 years is rotavirus. Consequently, for the World Health Organization and the Global Alliance for Vaccines and Immunization (GAVI), rotavirus vaccination is an urgent priority. The global distribution of rotavirus serotypes varies from country to country, but in 80-90% of cases is caused by five types: G1P[8], G2P[4], G3P[8], G4P[8] and G9P[8]. Currently, two rotavirus vaccines are available, an attenuated monovalent G1P[8] vaccine, and a pentavalent human-bovine recombinant vaccine containing five strains of bovine WC3 rotavirus, four with a gene codifying the VP7 protein of human rotaviruses G1, G2, G3 and G4, and a fifth expressing the VP4 P[8] genotype.</abstract><cop>Spain</cop><pmid>22112634</pmid><doi>10.1016/j.gastrohep.2011.09.003</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0210-5705
ispartof Gastroenterología y hepatología, 2011-12, Vol.34 (10), p.694-700
issn 0210-5705
language spa
recordid cdi_proquest_miscellaneous_909292656
source MEDLINE; Elsevier ScienceDirect Journals Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Diarrhea - prevention & control
Diarrhea - virology
Humans
Rotavirus Infections - prevention & control
Rotavirus Vaccines - adverse effects
Rotavirus Vaccines - immunology
title Rotavirus vaccines: a long and difficult journey
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T08%3A18%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rotavirus%20vaccines:%20a%20long%20and%20difficult%20journey&rft.jtitle=Gastroenterolog%C3%ADa%20y%20hepatolog%C3%ADa&rft.au=Campins%20Mart%C3%AD,%20Magda&rft.date=2011-12&rft.volume=34&rft.issue=10&rft.spage=694&rft.epage=700&rft.pages=694-700&rft.issn=0210-5705&rft_id=info:doi/10.1016/j.gastrohep.2011.09.003&rft_dat=%3Cproquest_pubme%3E909292656%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=909292656&rft_id=info:pmid/22112634&rfr_iscdi=true